KR20250048114A - 식욕부진을 조절 화합물 조성물 및 이의 이용 방법 - Google Patents

식욕부진을 조절 화합물 조성물 및 이의 이용 방법 Download PDF

Info

Publication number
KR20250048114A
KR20250048114A KR1020257009208A KR20257009208A KR20250048114A KR 20250048114 A KR20250048114 A KR 20250048114A KR 1020257009208 A KR1020257009208 A KR 1020257009208A KR 20257009208 A KR20257009208 A KR 20257009208A KR 20250048114 A KR20250048114 A KR 20250048114A
Authority
KR
South Korea
Prior art keywords
capromorelin
composition
day
treatment
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257009208A
Other languages
English (en)
Korean (ko)
Inventor
빌 졸러스
린다 로즈
에른스트 헤이넨
고피나트 데바라즈
Original Assignee
아라타나 세라퓨틱스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아라타나 세라퓨틱스, 인크. filed Critical 아라타나 세라퓨틱스, 인크.
Publication of KR20250048114A publication Critical patent/KR20250048114A/ko
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/132Heterocyclic compounds containing only one nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/20Feeding-stuffs specially adapted for particular animals for horses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Dermatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020257009208A 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법 Pending KR20250048114A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261706164P 2012-09-27 2012-09-27
US61/706,164 2012-09-27
KR1020237019962A KR20230097201A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
PCT/US2013/062227 WO2014052780A2 (en) 2012-09-27 2013-09-27 Compositions and methods of use of an inappetance-controlling compound

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020237019962A Division KR20230097201A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법

Publications (1)

Publication Number Publication Date
KR20250048114A true KR20250048114A (ko) 2025-04-07

Family

ID=50339468

Family Applications (6)

Application Number Title Priority Date Filing Date
KR1020257009208A Pending KR20250048114A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020217042990A Ceased KR20220003640A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020217001509A Ceased KR20210009438A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020157009647A Ceased KR20150058345A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020197037811A Ceased KR20190143484A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020237019962A Ceased KR20230097201A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법

Family Applications After (5)

Application Number Title Priority Date Filing Date
KR1020217042990A Ceased KR20220003640A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020217001509A Ceased KR20210009438A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020157009647A Ceased KR20150058345A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020197037811A Ceased KR20190143484A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법
KR1020237019962A Ceased KR20230097201A (ko) 2012-09-27 2013-09-27 식욕부진을 조절 화합물 조성물 및 이의 이용 방법

Country Status (18)

Country Link
US (1) US11090292B2 (https=)
EP (3) EP3524260B1 (https=)
JP (2) JP6779618B2 (https=)
KR (6) KR20250048114A (https=)
CN (2) CN111419845A (https=)
AR (2) AR092713A1 (https=)
AU (2) AU2013323349B2 (https=)
BR (1) BR112015006282B1 (https=)
CA (1) CA2886091C (https=)
DK (1) DK3524260T3 (https=)
ES (1) ES2959427T3 (https=)
MX (2) MX2015003564A (https=)
NZ (2) NZ746394A (https=)
PL (1) PL3524260T3 (https=)
PT (1) PT3524260T (https=)
RU (1) RU2648958C2 (https=)
TW (3) TWI732158B (https=)
WO (1) WO2014052780A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10975070B2 (en) 2010-02-26 2021-04-13 Raqualia Pharma Inc. Ghrelin receptor agonist for treatment of cachexia
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
BR112015006282B1 (pt) 2012-09-27 2021-11-23 Aratana Therapeutics, Inc Composições e usos de capromorelina para controle de inapetência
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
US9700591B2 (en) * 2015-01-28 2017-07-11 Aratana Therapeutics, Inc. Compositions and methods for chronic use of a weight-gaining compound
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
WO2018089723A1 (en) * 2016-11-11 2018-05-17 Hill's Pet Nutrition, Inc. Compositions and methods of pet food

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US193273A (en) * 1877-07-17 Improvement in material for pulley-covers
JP2893901B2 (ja) * 1990-09-07 1999-05-24 株式会社岐阜免疫研究所 動物用抗体含有油性ペースト製剤
CA2095786A1 (en) * 1992-05-08 1993-11-09 Franco J. Vaccarino Method of stimulating appetite
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
DE60140285D1 (de) 2000-05-31 2009-12-10 Pfizer Prod Inc Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts
EP1181933A3 (en) * 2000-06-29 2002-04-10 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating or increasing appetite
US8309603B2 (en) * 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
JP2007532495A (ja) * 2004-04-07 2007-11-15 ガストロテック・ファルマ・アクティーゼルスカブ グレリン欠乏を治療するための分泌促進薬の使用
WO2006045313A2 (en) * 2004-10-27 2006-05-04 Gastrotech Pharma A/S Uses of secretagogues for treatment of organ transplant patients
US8226973B2 (en) * 2005-11-02 2012-07-24 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
NZ571183A (en) * 2006-03-13 2010-09-30 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
US8299022B2 (en) 2006-09-27 2012-10-30 Ipsen Pharma S.A.S. Analogs of ghrelin substituted at the N-terminal
JP2008127377A (ja) * 2006-11-24 2008-06-05 Jichi Medical Univ Ghs−r作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。
US20080226802A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Beverage having natural sweeteners with one or more stevia components and source of berry
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
RU2007129408A (ru) * 2007-07-31 2009-02-10 Игорь Николаевич Жирков (RU) Способ выращивания поросят в период откорма
FR2920295B1 (fr) 2007-09-05 2009-12-11 Desvac Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
CN101854814B (zh) * 2007-11-12 2013-07-31 三荣源有限公司 改善甜叶菊提取物甜味的方法
EP2412713B1 (en) * 2009-03-26 2016-11-30 Takeda Pharmaceutical Company Limited Pyrazole compound
US10975070B2 (en) 2010-02-26 2021-04-13 Raqualia Pharma Inc. Ghrelin receptor agonist for treatment of cachexia
BR112015006282B1 (pt) 2012-09-27 2021-11-23 Aratana Therapeutics, Inc Composições e usos de capromorelina para controle de inapetência

Also Published As

Publication number Publication date
NZ746394A (en) 2019-01-25
EP2906041A2 (en) 2015-08-19
KR20220003640A (ko) 2022-01-10
JP6796097B2 (ja) 2020-12-02
WO2014052780A3 (en) 2014-06-26
KR20230097201A (ko) 2023-06-30
US20140088139A1 (en) 2014-03-27
CN105072909A (zh) 2015-11-18
JP6779618B2 (ja) 2020-11-04
AR123902A2 (es) 2023-01-25
PL3524260T3 (pl) 2023-11-27
MX2015003564A (es) 2015-11-16
CA2886091C (en) 2021-11-30
JP2016500660A (ja) 2016-01-14
AU2013323349B2 (en) 2016-09-15
BR112015006282A2 (pt) 2017-07-04
CN111419845A (zh) 2020-07-17
AU2016216741B2 (en) 2018-02-15
AU2016216741A1 (en) 2016-09-15
TW201417812A (zh) 2014-05-16
TWI732158B (zh) 2021-07-01
EP4302825A3 (en) 2024-07-03
AU2013323349A1 (en) 2015-05-07
ES2959427T3 (es) 2024-02-26
EP3524260B1 (en) 2023-09-13
US11090292B2 (en) 2021-08-17
EP2906041A4 (en) 2016-10-26
RU2648958C2 (ru) 2018-03-28
KR20150058345A (ko) 2015-05-28
WO2014052780A2 (en) 2014-04-03
JP2018117625A (ja) 2018-08-02
TWI667024B (zh) 2019-08-01
MX2022015141A (es) 2023-02-01
AR092713A1 (es) 2015-04-29
CA2886091A1 (en) 2014-04-03
KR20210009438A (ko) 2021-01-26
EP4302825A2 (en) 2024-01-10
BR112015006282B1 (pt) 2021-11-23
NZ707174A (en) 2018-10-26
RU2015114996A (ru) 2016-11-20
DK3524260T3 (da) 2023-10-09
KR20190143484A (ko) 2019-12-30
TW201924680A (zh) 2019-07-01
TW202106298A (zh) 2021-02-16
EP3524260A1 (en) 2019-08-14
PT3524260T (pt) 2023-10-13

Similar Documents

Publication Publication Date Title
AU2016216741B2 (en) Compositions and methods of use of an inappetance-controlling compound
JP7120718B2 (ja) 体重増加用化合物の長期使用のための組成物と方法
HK40104431A (en) Pharmaceutical compositions for treatment of inappetence

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20250320

Application number text: 1020237019962

Filing date: 20230614

PA0201 Request for examination
PG1501 Laying open of application